Drug of abuse testing is a process of identification of illegal drugs in blood, urine, saliva and others. The drugs include cocaine, opiates, marijuana, methamphetamine, benzodiazepine, methadone, ecstasy, amphetamine, barbiturates, PCP and others. Drug of abuse testing is a qualitative process and mostly performed in clinical settings.
Lantern Pharma is a clinical stage biotechnology company focused on leveraging artificial intelligence (“A.I.”), machine learning and genomic date to streamline the drug development process and to identify patients who will benefit from their targeted oncology therapies. Their portfolio of therapies consists of compounds that others have tried, but failed, to develop into an approved commercialized drug. Additionally, they develop new compounds with the assistance of their A.I. platform (RADR) and biomarker driven approach. The Company is currently developing four therapeutic programs.
This report examines CMS's oversight of Medicare Part D beneficiaries who receive opioid prescriptions and providers who prescribe opioids to these beneficiaries. It finds that while CMS provides guidance to Part D plan sponsors on monitoring beneficiaries at high risk of opioid overuse, it lacks complete data on the full population of beneficiaries at risk. It also finds that CMS oversees prescribing through its contractor NBI MEDIC but does not specifically analyze opioid prescription data or require reporting on actions taken regarding inappropriate opioid prescribing. The report concludes that CMS needs more comprehensive oversight to reduce the risks of opioid misuse, overdose, and inappropriate prescribing among Medicare beneficiaries.
This document provides a summary of the Oncology Drug Report 2014, which is described as the world's largest active resource for decision making in oncology. Some key details include:
- It covers 931 active cancer drug developers across 33 countries, along with profiles of 2237 active drugs in development, 37 cancer indications under pipeline analysis, and 523 clinical and 360 preclinical and discovery companies.
- The report is organized across 6 sections and provides comprehensive intelligence on the global oncology drug development landscape, including clinical trials, targets, mechanisms of action, deals and partnerships for individual drugs and companies.
- It aims to help businesses, scientists, investors and clinicians make better decisions by bringing extensive data together in one place
This document summarizes a study conducted by the U.S. Department of Commerce on pharmaceutical price controls in OECD countries and their implications. The key findings are:
1) All 11 OECD countries studied rely on some form of price controls to limit drug spending, resulting in patented drug prices below U.S. levels.
2) Intellectual property rights are adequately enforced in these countries, but price controls still reduce revenues that could support more research and development.
3) Estimates suggest price controls reduce annual global pharmaceutical R&D by $5-8 billion and new drug development by 3-4 drugs per year.
4) Eliminating price controls could provide U.S. consumers $5-
New technologies and the outsourcing of clinical trials to lower-cost countries will slow the recent annual increases in expenditures in the U.S. to a 3.3% compound annual growth rate (CAGR) over the forecast period.
Global orphan drug market future outlook 2020Rajesh Sarma
"Global Orphan Drug Market Future Outlook 2020" report highlights:
Global Orphan Drug Market Overview
Global Orphan Drug Market Segment Analysis
FDA & EMA Regulation for Clinical Trials Orphan Designated Drugs
Orphan Drug Designation Criteria & Reimbursement Policy by Region
Comprehensive Insight on Global Orphan Drugs Clinical Pipeline & Patent Analysis by Company, Country, Indication & Phase
Global Orphan Drugs Clinical Pipeline: 697 Drugs
Majority Orphan Drugs in Phase-II Trials: 249 Drugs
Marketed Orphan Drugs: 274 Drugs
“US Orphan Drug Market Outlook 2018” research report by KuicK Research comprehensive insight on following developments related to US orphan drug market:
US Orphan Drug Market Overview
Orphan Drug Designation Criteria
Market Specific Reimbursement Policy & Regulatory Framework
US Orphan Drug Pipeline by Phase, Indication & Originator
Marketed Orphan drug List by Indication & Brand Name
Key Issue to be Resolved
Competitive Landscape
Lantern Pharma is a clinical stage biotechnology company focused on leveraging artificial intelligence (“A.I.”), machine learning and genomic date to streamline the drug development process and to identify patients who will benefit from their targeted oncology therapies. Their portfolio of therapies consists of compounds that others have tried, but failed, to develop into an approved commercialized drug. Additionally, they develop new compounds with the assistance of their A.I. platform (RADR) and biomarker driven approach. The Company is currently developing four therapeutic programs.
This report examines CMS's oversight of Medicare Part D beneficiaries who receive opioid prescriptions and providers who prescribe opioids to these beneficiaries. It finds that while CMS provides guidance to Part D plan sponsors on monitoring beneficiaries at high risk of opioid overuse, it lacks complete data on the full population of beneficiaries at risk. It also finds that CMS oversees prescribing through its contractor NBI MEDIC but does not specifically analyze opioid prescription data or require reporting on actions taken regarding inappropriate opioid prescribing. The report concludes that CMS needs more comprehensive oversight to reduce the risks of opioid misuse, overdose, and inappropriate prescribing among Medicare beneficiaries.
This document provides a summary of the Oncology Drug Report 2014, which is described as the world's largest active resource for decision making in oncology. Some key details include:
- It covers 931 active cancer drug developers across 33 countries, along with profiles of 2237 active drugs in development, 37 cancer indications under pipeline analysis, and 523 clinical and 360 preclinical and discovery companies.
- The report is organized across 6 sections and provides comprehensive intelligence on the global oncology drug development landscape, including clinical trials, targets, mechanisms of action, deals and partnerships for individual drugs and companies.
- It aims to help businesses, scientists, investors and clinicians make better decisions by bringing extensive data together in one place
This document summarizes a study conducted by the U.S. Department of Commerce on pharmaceutical price controls in OECD countries and their implications. The key findings are:
1) All 11 OECD countries studied rely on some form of price controls to limit drug spending, resulting in patented drug prices below U.S. levels.
2) Intellectual property rights are adequately enforced in these countries, but price controls still reduce revenues that could support more research and development.
3) Estimates suggest price controls reduce annual global pharmaceutical R&D by $5-8 billion and new drug development by 3-4 drugs per year.
4) Eliminating price controls could provide U.S. consumers $5-
New technologies and the outsourcing of clinical trials to lower-cost countries will slow the recent annual increases in expenditures in the U.S. to a 3.3% compound annual growth rate (CAGR) over the forecast period.
Global orphan drug market future outlook 2020Rajesh Sarma
"Global Orphan Drug Market Future Outlook 2020" report highlights:
Global Orphan Drug Market Overview
Global Orphan Drug Market Segment Analysis
FDA & EMA Regulation for Clinical Trials Orphan Designated Drugs
Orphan Drug Designation Criteria & Reimbursement Policy by Region
Comprehensive Insight on Global Orphan Drugs Clinical Pipeline & Patent Analysis by Company, Country, Indication & Phase
Global Orphan Drugs Clinical Pipeline: 697 Drugs
Majority Orphan Drugs in Phase-II Trials: 249 Drugs
Marketed Orphan Drugs: 274 Drugs
“US Orphan Drug Market Outlook 2018” research report by KuicK Research comprehensive insight on following developments related to US orphan drug market:
US Orphan Drug Market Overview
Orphan Drug Designation Criteria
Market Specific Reimbursement Policy & Regulatory Framework
US Orphan Drug Pipeline by Phase, Indication & Originator
Marketed Orphan drug List by Indication & Brand Name
Key Issue to be Resolved
Competitive Landscape
This document discusses redesigning post-market drug safety surveillance. It proposes developing an integrated commercial off-the-shelf post-market surveillance platform to analyze real-world data on prescribing, patient outcomes, and adverse events in a standardized way. This could provide valuable insight into drug safety and efficacy using real-world evidence from clinical practice settings. Currently, post-market surveillance relies on voluntary reporting which results in underreporting and limited data for analyzing trends. The proposed platform aims to address these limitations through consistent analysis of real-world data sources.
China Pharmaceutical Market : SWOT Analysis, Government policies, Business an...Maria Robert
Purchase a copy of this report @ http://www.lifescienceindustryresearch.com/purchase?rname=17129.
Pharmaceutical Industry in China – Cutting-Edge Analysis of Multinational and Chinese Pharma Companies, Industry Trends, Environment, Regulation, Market Drivers, Restraints, Opportunities & Challenges report presented by Company (e.g., AMOYTOP BIOTECH, BEIJING CONTINENT PHARMACEUTICALS, FUSOGEN, SHANGHAI HUAGUAN BIOCHIP, SIBIONO GENETECH, ABBOTT, ROCHE, PFIZER, GSK, NOVARTIS) & by Therapeutic Area (e.g., Anti-infective, Cancer, Diabetes, Dementia, Depression)
ResearchMoz - Polymerase chain reaction (pcr) in medical application an analy...QYResearchReports
Researchmoz presents this most up-to-date research on " ResearchMoz - Polymerase chain reaction (pcr) in medical application an analytical report, 2009-2015 ". The report focuses primarily on quantitative market metrics in
order to characterize the growth and evolution.
he global PCR market is projected to reach around US$27.4 billion by 2015, with a Compounded Annual Growth Rate (CAGR) of 13.9% for the analysis period, 2009-2015. North America is estimated as the largest market with a market share of 40% of global market and projects US$10.7 billion by end-2010. Europe and Asia-Pacific together account for more than 50% of the global market share. Interestingly, Latin America is seen as the fastest growing market with a CAGR of 14.8%, to worth around US$1.3 billion in 2015.
The document discusses biomarkers and their use in disease diagnosis, drug development, and other applications. It provides an overview of the global biomarkers market, expected to reach $30.6 billion by 2020, with disease diagnosis as the major application. The market is analyzed by type, application, services, and geography. Key players in the biomarkers industry are also profiled.
Big Data in Drug Safety: Making post-marketing surveillance in pharmacovigila...Arete-Zoe, LLC
The paper makes a case for change in the way data on the safety of medicines is collected, structured, analyzed, visualized, and shared. Post-market surveillance shall move away from active reporting of individual case reports into national and international databases toward the collection and analysis of anonymous structured summary data from health care providers. The objective is to enable an analysis of total numbers of treated patients and treatment outcomes, including adverse drug reactions and off-label drug use, to provide meaningful, population-based, statistically valid, bias-free, real-time information on safety and efficacy of products on the market without endangering patients' privacy. Such approach would significantly reduce privacy concerns and add value for stakeholders who are interested in timely and accurate information on benefit:risk profile of medicinal products.
This document summarizes national trends in prescription drug expenditures in the United States for 2015 and provides projections for 2016. Key findings include:
- Total US prescription drug sales in 2015 were $419.4 billion, an 11.7% increase over 2014. Spending in clinics and non-federal hospitals increased 15.9% and 10.7%, respectively.
- Growth in overall spending was driven primarily by price increases for existing drugs (8.4%), with new drugs (2.7%) and changes in drug usage (0.5%) also contributing. Hospital spending growth was mainly from price increases, while clinic growth was mostly from increased drug usage.
- Projections estimate an 11-13%
Pharmaceutical pricing and reimbursement usaNeha Kalal
This document provides an overview of pharmaceutical pricing and reimbursement in the United States. It discusses key demographics and economic factors, the major public and private healthcare programs, and how drug pricing and reimbursement works. The US healthcare system is complex, with prescription drugs constituting 12% of total spending. Major public programs include Medicare, Medicaid, and CHIP, while private sources include employer and individual insurance plans. Pharmaceutical companies set prices freely, while payers determine reimbursement levels and use formularies, tiers, and cost-sharing to manage drug costs.
United states breast cancer diagnostic devices market 2010 2020 brochurePharmaion
According to Pharmaion “United States Breast Cancer Diagnostic Devices Market Opportunities, 2010 - 2020” report studies the market size and share of various segments and sub-segments of the breast cancer diagnostic devices market in the United States during the period 2010 - 2020.
Global market size in drug lead and precursorPriya Saraf
The document discusses the global market size of drug leads, precursors, and drug discovery outsourcing. It provides insights into market trends such as:
1) The global drug discovery outsourcing market was estimated at $2.19 billion in 2016 and is expected to witness rapid growth due to increased outsourcing and investments in drug discovery R&D.
2) North America dominated the market in 2016, while Asia Pacific is expected to grow the fastest during 2020-2025 due to growth in pharmaceutical industries and less stringent regulations.
3) The beta-carotene market is driven by its use as a natural colorant and precursor to vitamin A to treat deficiencies, and in pharmaceuticals and
Molecular diagnostics market & forecast (by application, technology, countrie...Renub Research
Renub Research (http://renub.com/report/molecular-diagnostics-market-forecast-by-application-technology-countries-companies-clinical-trials-to-2017-global-analysis-114) has announced the addition of the "Molecular Diagnostics Market & Forecast (By Application, Technology, Countries, Companies & Clinical Trials) to 2017: Global Analysis" report to its offering
According to the latest report by IMARC Group,the global gene expression analysis marketexhibited strong growth during 2015-2020.
Gene expression analysis is extensively used across clinical, research and pharmaceutical settings to study individual genes, gene pathways or greater gene activity profiles.
Thomas Müller, MD & Pharmacist, Head of Pharmaceuticals Dept Federal Joint Committee.
Pharma Pricing & Market Access Congress 2017
22 February 2017
London
The document provides an overview of the global liquid biopsy market forecast from 2020 to 2025. It discusses key aspects of the market such as application, end user, clinical application, product/service, circulating biomarker, technology, and region. It also profiles major companies in the market and their recent developments. The global liquid biopsy market is expected to grow significantly due to the rising adoption of non-invasive cancer screening and monitoring techniques. However, lack of standardization and low reimbursement rates may hinder the market growth.
China pharmaceutical business market forecast and investment strategy report,...Qianzhan Intelligence
This document provides an overview and summary of the Chinese Pharmaceutical Business Market Forecast and Investment Strategy Report from 2013 to 2017. It discusses the objectives and importance of the report, which is to provide an accurate and comprehensive analysis of the pharmaceutical business industry in China. This includes analyzing aspects such as industry policies, economic environment, market demand, development status and prospects, competition among major companies, status of pharmaceutical wholesaling and logistics markets, and more. The document emphasizes the report's focus on insight and timeliness to help readers understand the latest industry trends and make correct business and investment decisions.
This document summarizes analysis of unpartnered pharmaceutical products from Medtrack in September 2015. It finds that opportunities remain abundant, with many preclinical and early-stage candidates in private company pipelines as well as late-stage candidates in public company pipelines. Oncology remains the leading therapeutic area for unpartnered drugs. Several private and public companies are highlighted that have significant unpartnered pipelines that could be candidates for partnership or acquisition deals. The document analyzes Phase III candidates in more detail and finds some oncology drugs that have above average likelihood of approval based on proprietary modeling.
Blood culture test market Research, Industry Trends, Strategies, Growth, Regi...IMARC Group
The document provides information about IMARC Group, a market research firm. It details their expertise in areas such as market intelligence, business insights, competitive intelligence, strategy consulting, consumer surveys, and market entry strategies. It serves various industries including food and beverages, chemicals, FMCG, healthcare, machinery, and others. The document also highlights testimonials from clients praising IMARC's domain expertise, data provision for any market, and ability to provide innovative solutions.
Coagulation Analyzer Market Analysis and Price Trends, 2018 to 2024Signitech
The document summarizes a market research report on the global coagulation analyzers/reagents market. Some key points:
- The global market is expected to reach $7.9 billion by 2024, growing at a CAGR of 10.2% from 2015 to 2024.
- Technological advancements in coagulation analyzers, including combination assays and automation, are driving market growth. Clinical laboratory analyzers currently dominate the market.
- By product, the market is segmented into analyzers like clinical laboratory and point-of-care analyzers, and consumables like reagents. The largest segments are clinical laboratory analyzers and reagents.
- Geographically, North America currently holds the
What are the liquid biopsy fundamentals? What are the goals of liquid biopsy? What are the market trends in liquid biopsy? Who's investing in liquid biopsy? What biomarkers are driving liquid biopsy?
Global artificial intelligenceGlobal Artificial Intelligence (AI) for Drug Di...GMI Research
This document provides an overview and market analysis of the global artificial intelligence (AI) drug discovery market from 2018 to 2025. It discusses key topics like market segmentation based on drug type, technology used, therapeutic areas, end users, and geographic regions. It also profiles major players in the industry and provides revenue forecasts for the total market and segments. The global AI drug discovery market is rapidly growing due to factors like increasing partnerships and venture capital investments, and rising R&D spending on using AI for drug discovery. However, reluctance among medical practitioners to adopt AI and lack of interoperability between vendor solutions may impede market growth.
Introduction to the pharmaceutical market and practiceWayne Wei
As a lecturer for "Basic Principles of Drug Discovery and Development" for Department of Life Sciences, National Central of University for two years.
In charge of "Introduction to the pharmaceutical market and practice".
Contract research organization services (cr os) marketameliasimon0
Contract research organizations (CROs) provide support services and clinical trial management for pharmaceutical, biotech, medical device, and other healthcare companies. This document analyzes the global CRO market size and trends between 2019-2025. It finds that the market is growing due to increased outsourcing of research and development activities and rising clinical trial numbers. However, shortages of skilled professionals may restrain growth. The market is segmented by therapeutic area, services type, and end user, with oncology and pharmaceutical companies representing large segments.
Clinical trial is a medical research study performed on humans to check the safety and efficacy of drugs, devices and therapeutic products before they are finally launched in the market. Proper management of clinical trials has become a priority for hospitals, pharmaceutical companies and clinical research organizations (CRO).
This document discusses redesigning post-market drug safety surveillance. It proposes developing an integrated commercial off-the-shelf post-market surveillance platform to analyze real-world data on prescribing, patient outcomes, and adverse events in a standardized way. This could provide valuable insight into drug safety and efficacy using real-world evidence from clinical practice settings. Currently, post-market surveillance relies on voluntary reporting which results in underreporting and limited data for analyzing trends. The proposed platform aims to address these limitations through consistent analysis of real-world data sources.
China Pharmaceutical Market : SWOT Analysis, Government policies, Business an...Maria Robert
Purchase a copy of this report @ http://www.lifescienceindustryresearch.com/purchase?rname=17129.
Pharmaceutical Industry in China – Cutting-Edge Analysis of Multinational and Chinese Pharma Companies, Industry Trends, Environment, Regulation, Market Drivers, Restraints, Opportunities & Challenges report presented by Company (e.g., AMOYTOP BIOTECH, BEIJING CONTINENT PHARMACEUTICALS, FUSOGEN, SHANGHAI HUAGUAN BIOCHIP, SIBIONO GENETECH, ABBOTT, ROCHE, PFIZER, GSK, NOVARTIS) & by Therapeutic Area (e.g., Anti-infective, Cancer, Diabetes, Dementia, Depression)
ResearchMoz - Polymerase chain reaction (pcr) in medical application an analy...QYResearchReports
Researchmoz presents this most up-to-date research on " ResearchMoz - Polymerase chain reaction (pcr) in medical application an analytical report, 2009-2015 ". The report focuses primarily on quantitative market metrics in
order to characterize the growth and evolution.
he global PCR market is projected to reach around US$27.4 billion by 2015, with a Compounded Annual Growth Rate (CAGR) of 13.9% for the analysis period, 2009-2015. North America is estimated as the largest market with a market share of 40% of global market and projects US$10.7 billion by end-2010. Europe and Asia-Pacific together account for more than 50% of the global market share. Interestingly, Latin America is seen as the fastest growing market with a CAGR of 14.8%, to worth around US$1.3 billion in 2015.
The document discusses biomarkers and their use in disease diagnosis, drug development, and other applications. It provides an overview of the global biomarkers market, expected to reach $30.6 billion by 2020, with disease diagnosis as the major application. The market is analyzed by type, application, services, and geography. Key players in the biomarkers industry are also profiled.
Big Data in Drug Safety: Making post-marketing surveillance in pharmacovigila...Arete-Zoe, LLC
The paper makes a case for change in the way data on the safety of medicines is collected, structured, analyzed, visualized, and shared. Post-market surveillance shall move away from active reporting of individual case reports into national and international databases toward the collection and analysis of anonymous structured summary data from health care providers. The objective is to enable an analysis of total numbers of treated patients and treatment outcomes, including adverse drug reactions and off-label drug use, to provide meaningful, population-based, statistically valid, bias-free, real-time information on safety and efficacy of products on the market without endangering patients' privacy. Such approach would significantly reduce privacy concerns and add value for stakeholders who are interested in timely and accurate information on benefit:risk profile of medicinal products.
This document summarizes national trends in prescription drug expenditures in the United States for 2015 and provides projections for 2016. Key findings include:
- Total US prescription drug sales in 2015 were $419.4 billion, an 11.7% increase over 2014. Spending in clinics and non-federal hospitals increased 15.9% and 10.7%, respectively.
- Growth in overall spending was driven primarily by price increases for existing drugs (8.4%), with new drugs (2.7%) and changes in drug usage (0.5%) also contributing. Hospital spending growth was mainly from price increases, while clinic growth was mostly from increased drug usage.
- Projections estimate an 11-13%
Pharmaceutical pricing and reimbursement usaNeha Kalal
This document provides an overview of pharmaceutical pricing and reimbursement in the United States. It discusses key demographics and economic factors, the major public and private healthcare programs, and how drug pricing and reimbursement works. The US healthcare system is complex, with prescription drugs constituting 12% of total spending. Major public programs include Medicare, Medicaid, and CHIP, while private sources include employer and individual insurance plans. Pharmaceutical companies set prices freely, while payers determine reimbursement levels and use formularies, tiers, and cost-sharing to manage drug costs.
United states breast cancer diagnostic devices market 2010 2020 brochurePharmaion
According to Pharmaion “United States Breast Cancer Diagnostic Devices Market Opportunities, 2010 - 2020” report studies the market size and share of various segments and sub-segments of the breast cancer diagnostic devices market in the United States during the period 2010 - 2020.
Global market size in drug lead and precursorPriya Saraf
The document discusses the global market size of drug leads, precursors, and drug discovery outsourcing. It provides insights into market trends such as:
1) The global drug discovery outsourcing market was estimated at $2.19 billion in 2016 and is expected to witness rapid growth due to increased outsourcing and investments in drug discovery R&D.
2) North America dominated the market in 2016, while Asia Pacific is expected to grow the fastest during 2020-2025 due to growth in pharmaceutical industries and less stringent regulations.
3) The beta-carotene market is driven by its use as a natural colorant and precursor to vitamin A to treat deficiencies, and in pharmaceuticals and
Molecular diagnostics market & forecast (by application, technology, countrie...Renub Research
Renub Research (http://renub.com/report/molecular-diagnostics-market-forecast-by-application-technology-countries-companies-clinical-trials-to-2017-global-analysis-114) has announced the addition of the "Molecular Diagnostics Market & Forecast (By Application, Technology, Countries, Companies & Clinical Trials) to 2017: Global Analysis" report to its offering
According to the latest report by IMARC Group,the global gene expression analysis marketexhibited strong growth during 2015-2020.
Gene expression analysis is extensively used across clinical, research and pharmaceutical settings to study individual genes, gene pathways or greater gene activity profiles.
Thomas Müller, MD & Pharmacist, Head of Pharmaceuticals Dept Federal Joint Committee.
Pharma Pricing & Market Access Congress 2017
22 February 2017
London
The document provides an overview of the global liquid biopsy market forecast from 2020 to 2025. It discusses key aspects of the market such as application, end user, clinical application, product/service, circulating biomarker, technology, and region. It also profiles major companies in the market and their recent developments. The global liquid biopsy market is expected to grow significantly due to the rising adoption of non-invasive cancer screening and monitoring techniques. However, lack of standardization and low reimbursement rates may hinder the market growth.
China pharmaceutical business market forecast and investment strategy report,...Qianzhan Intelligence
This document provides an overview and summary of the Chinese Pharmaceutical Business Market Forecast and Investment Strategy Report from 2013 to 2017. It discusses the objectives and importance of the report, which is to provide an accurate and comprehensive analysis of the pharmaceutical business industry in China. This includes analyzing aspects such as industry policies, economic environment, market demand, development status and prospects, competition among major companies, status of pharmaceutical wholesaling and logistics markets, and more. The document emphasizes the report's focus on insight and timeliness to help readers understand the latest industry trends and make correct business and investment decisions.
This document summarizes analysis of unpartnered pharmaceutical products from Medtrack in September 2015. It finds that opportunities remain abundant, with many preclinical and early-stage candidates in private company pipelines as well as late-stage candidates in public company pipelines. Oncology remains the leading therapeutic area for unpartnered drugs. Several private and public companies are highlighted that have significant unpartnered pipelines that could be candidates for partnership or acquisition deals. The document analyzes Phase III candidates in more detail and finds some oncology drugs that have above average likelihood of approval based on proprietary modeling.
Blood culture test market Research, Industry Trends, Strategies, Growth, Regi...IMARC Group
The document provides information about IMARC Group, a market research firm. It details their expertise in areas such as market intelligence, business insights, competitive intelligence, strategy consulting, consumer surveys, and market entry strategies. It serves various industries including food and beverages, chemicals, FMCG, healthcare, machinery, and others. The document also highlights testimonials from clients praising IMARC's domain expertise, data provision for any market, and ability to provide innovative solutions.
Coagulation Analyzer Market Analysis and Price Trends, 2018 to 2024Signitech
The document summarizes a market research report on the global coagulation analyzers/reagents market. Some key points:
- The global market is expected to reach $7.9 billion by 2024, growing at a CAGR of 10.2% from 2015 to 2024.
- Technological advancements in coagulation analyzers, including combination assays and automation, are driving market growth. Clinical laboratory analyzers currently dominate the market.
- By product, the market is segmented into analyzers like clinical laboratory and point-of-care analyzers, and consumables like reagents. The largest segments are clinical laboratory analyzers and reagents.
- Geographically, North America currently holds the
What are the liquid biopsy fundamentals? What are the goals of liquid biopsy? What are the market trends in liquid biopsy? Who's investing in liquid biopsy? What biomarkers are driving liquid biopsy?
Global artificial intelligenceGlobal Artificial Intelligence (AI) for Drug Di...GMI Research
This document provides an overview and market analysis of the global artificial intelligence (AI) drug discovery market from 2018 to 2025. It discusses key topics like market segmentation based on drug type, technology used, therapeutic areas, end users, and geographic regions. It also profiles major players in the industry and provides revenue forecasts for the total market and segments. The global AI drug discovery market is rapidly growing due to factors like increasing partnerships and venture capital investments, and rising R&D spending on using AI for drug discovery. However, reluctance among medical practitioners to adopt AI and lack of interoperability between vendor solutions may impede market growth.
Introduction to the pharmaceutical market and practiceWayne Wei
As a lecturer for "Basic Principles of Drug Discovery and Development" for Department of Life Sciences, National Central of University for two years.
In charge of "Introduction to the pharmaceutical market and practice".
Contract research organization services (cr os) marketameliasimon0
Contract research organizations (CROs) provide support services and clinical trial management for pharmaceutical, biotech, medical device, and other healthcare companies. This document analyzes the global CRO market size and trends between 2019-2025. It finds that the market is growing due to increased outsourcing of research and development activities and rising clinical trial numbers. However, shortages of skilled professionals may restrain growth. The market is segmented by therapeutic area, services type, and end user, with oncology and pharmaceutical companies representing large segments.
Clinical trial is a medical research study performed on humans to check the safety and efficacy of drugs, devices and therapeutic products before they are finally launched in the market. Proper management of clinical trials has become a priority for hospitals, pharmaceutical companies and clinical research organizations (CRO).
Anal Cancer Market 2023: Epidemiology, Industry Trends, Size, Share And Forec...frankmorgan27
The Anal Cancer Market report thoroughly examines the market size, latest trends, and growth forecast. The report includes an overview of the disease and market scenario, as well as market trends, growth prospects, investment opportunities, and industry prospects. Additionally, it provides competitor analysis, regional analysis, and recent advancements in the Anal Cancer Market.
Pompe Disease Treatment Market Growth, Demand and Challenges of the Key Indus...IMARC Group
The global Pompe disease treatment market size reached US$ 1.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 1.3 Billion by 2032, exhibiting a growth rate (CAGR) of 2.58% during 2024-2032.
More Info:- https://www.imarcgroup.com/pompe-disease-treatment-market
Sandhoff Disease Market 2023: Epidemiology, Industry Trends, Size, Share And ...frankmorgan27
The growing cases of lipid storage disorders owing to the inherited deficiencies in producing functional catabolic enzymes are primarily augmenting the Sandhoff disease market.
MarketResearchReports.com has announced the addition of “Forecast of Global Clinical Trial Supplies Consumption Market Report 2023” research report to their offering. See more at- http://mrr.cm/wWQ
Pharmacy and over the-counter (otc) cans market global trends, market share, ...Shubham Bhosale
Over-the-counter (OTC) drug sales are increasing as self-medication becomes more common. Pharmaceutical packaging, including OTC cans, plays an important role in ensuring drug stability and safety. The global OTC cans market is led by North America and Europe and is expected to grow as emerging markets increase pharmaceutical production. Key factors influencing the market include demand for various materials like plastic and regulations around environmental packaging.
Multiple myeloma therapeutics in major developed markets to 2021 growth dri...David2591
Most up-to-date research on "Multiple Myeloma Therapeutics in Major Developed Markets to 2021 - Growth Driven by Rising Prevalence, Continued Success of Revlimid and Emerging Supplementary Treatments" to its huge collection of research reports.
Pharmacovigilance Market was valued at US$ 8.5 billion in 2024 and is project...ankitakalvankar
Pharmacovigilance Market, By Clinical Trial Phase (Preclinical, Phase I, Phase II, Phase III, and Phase IV), By Service Provider (In-house, Contract, and Outsourcing), By Type of Reporting (Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, and EHR Mining), By End User (Hospitals, Pharmaceutical Companies, and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2034
Point of care testing market and forecast to 2016 global analysisRenub Research
Renub Research (http://www.renub.com/report/point-of-care-testing-market-and-forecast-to-2016-global-analysis-88) has announced the addition of the "Point of Care Testing Market and Forecast to 2016: Global Analysis" report to its offering
Point of Care Testing Market and Forecast to 2016: Global Analysis - Market Overview
The concept of Point of Care Testing (POCT), also known as bedside, near-patient testing and decentralized testing, relates to tests that are conducted by clinical operators at the site of patient care where immediate medical action is taken on the results. The fact that point of care (POCT) represents a departure from conventional laboratory medicine has created new opportunities in the field of diagnostics industry. Technical advancements over recent years have helped point of care testing (POCT) to grow with double digit CAGR from 2009 to 2011 and evolve into a vital diagnostic tool. It is predicted that point of care testing market will be approximately US$ 25 Billion by 2016.
Blood glucose test controls a lion’s market share of around 70% for the year 2011 and it is expected to continue its dominance till 2016. Rest of all the others point of care tests market share covered in this report are in single digit. Infectious disease testing market is expected to double by 2016 from its market of 2011. As countries are making the healthcare more and more accessible to people, the demand for various point of care testing is keep on rising. The point of care testing market has become an established sector worldwide and will continue to provide vital contribution in in-vitro diagnostics industry.
This 83 page report contains 26 Figures and 12 Tables provides a comprehensive analysis of the emerging point of care tests market segments, including their dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. Renub Research report entitled “Point of Care Testing Market and Forecast to 2016: Global Analysis” report also provides market landscape and market share information in the point of care testing market. The report brings together major merger & acquisition, distribution agreement, licensing deals information in point of care testing market. The report also entails major drivers and challenges of point of care testing market.
10 Point of Care Test Segments Covered in this Report
Blood Glucose Testing, Cardiac Marker Testing, Lipid Panel/Cholesterol Testing, Blood Coagulation Testing, Infectious Disease Testing, Urinalysis Testing, Drug of Abuse Testing, Fecal Occult Blood Testing, Pregnancy & Fertility Testing and Tumor Marker Testing
Orphan drugs market Report with Leading Competitor Analysis, Strategies and F...IMARC Group
The global orphan drugs market exhibited moderate growth during 2014-2019. Looking forward, IMARC Group expects the global orphan drugs market to exhibit moderate growth during the next five years.
To learn more about this market, visit us at: https://www.imarcgroup.com/orphan-drugs-market
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
The report provides an analysis of the key trends in each sub-segment of the global orphan drugs market report, along with forecasts for growth at the global, regional and country level from 2020-2025. The competitive landscape of the market has also been analyzed in the report with the detailed profiles of the key players.
For more information, request for a free sample report here: https://www.imarcgroup.com/orphan-drugs-market/requestsample
Contact Us:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
Migraine Drugs Market by Product Type, Distribution Channel, End User 2024-2032IMARC Group
The global migraine drugs market size reached US$ 4.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 6.3 Billion by 2032, exhibiting a growth rate (CAGR) of 4.3% during 2024-2032.
More Info:- https://www.imarcgroup.com/migraine-drugs-market
Minimal Residual Disease Market 2023: Epidemiology, Industry Trends, Size, Sh...frankmorgan27
The rising instances of hematologic malignancies and the inflating need to treat these conditions using radiotherapy and chemotherapy are primarily driving the minimal residual disease market.
Personalized Medicine Diagnostics (Flow Cytometry, Sepsis Immunos, Routine Co...Renub Research
Renub Research (http://www.renub.com/report/personalized-medicine-diagnostics-flow-cytometry-sepsis-immunos-routine-coagulation-psychiatric-disorders-tumor-markers-molecular-blood-typing-and-other-testing-116) has announced the addition of the "Personalized Medicine Diagnostics (Flow Cytometry, Sepsis Immunos, Routine Coagulation, Psychiatric Disorders, Tumor Markers, Molecular Blood Typing and Other Testing)" report to its offering
United States Diagnostics Market Size, Share, Trend and Forecast 2026 | TechS...TechSci Research
According to #TechSci Research report, United States Diagnostics Market stood at USD30.08billion in 2020 and is expected to grow at a steady rate of 5.17% during the forecast period.
Gain More Insight: https://bit.ly/3wWI0do
Get Sample Report: https://bit.ly/3ltFdo6
Website: https://www.techsciresearch.com/
Market Research News: https://techsciblog.com/
Biological Safety Testing Market Size, Product Analysis and Applications, 201...Signitech
The global biological safety testing market size was valued at USD 2.20 billion in 2016 and is anticipated to exhibit a CAGR of 12.2% during the forecast period.
COPD Drugs Market by Type (Bronchodilators, PDE-4 Inhibitors, Steroids, Combination Therapies, Others), Application (Hospitals, Clinics, Others), and Geography – Global Trends & Forecasts to 2019-2029
Similar to Drug of abuse testing market global trends, market share, industry size, growth, opportunities, and market forecast 2019 to 2026 (20)
Asia pacific wound care market global trends, market share, industry size, gr...Shubham Bhosale
FutureWise Market Research has illustrated a report on the Asia Pacific Wound Care Market. The report provides an in-depth analysis of growth trends affecting the market. Moreover, it includes intricate insights on profitability graph, market share, SWOT analysis and geographical augmentation of this business.
Anti microbial packaging market global trends, market share, industry size, g...Shubham Bhosale
The global antimicrobial packaging market is expected to grow at a CAGR of 5.44% through 2026. Demand is driven by consumer awareness of organic foods and regulations requiring safer packaging. Antimicrobial packaging prevents contamination and degradation of packaged products like food and drugs by inhibiting microbial growth. Plastics are commonly used but biopolymers and paperboards are growing in popularity due to environmental concerns. Pouches are the most popular product type. The pharmaceutical industry is a major end user of antimicrobial packaging. The market is led by companies like BASF, PolyOne, and Dow Chemical which provide innovative antimicrobial packaging materials and solutions.
Patient flow management is a one-stop software solution to manage all the patient information in hospitals and plays a vital role in customer feedback and satisfaction. Reforming healthcare management and infrastructure in developing nations is expected to drive growth for global patient flow management solutions market during the forecast period.
Automotive 3 d printing market global trends, market share, industry size, gr...Shubham Bhosale
Automotive engineering prototypes involve complex mechanical geometric blueprints widely used in the manufacturing process of various automotive parts. Advanced 3D printing technology utilizes precision based high-resolution design tools reducing the human errors, cost, time and customization efforts as compared to traditional ways. Layer by layer depositing of raw material using 3D printing facilitates substantial material wastage reduction.
Anti microbial packaging market global trends, market share, industry size, g...Shubham Bhosale
The demand for preservative-free and relatively less processed bio essential commodities such as packaged food, health supplements and nutrients is rising due to general awareness about the benefits of organic and non-processed food items. The antimicrobial packaging ensures the shelf life is extended and is safe for consumption by the time the products reaches the consumers.
Artificial intelligence in healthcare market global trends, market share, ind...Shubham Bhosale
The document discusses the global artificial intelligence in healthcare market. It predicts the market will be worth over $37 billion by 2029, growing at a CAGR of over 50% from 2019 to 2029. The increasing amounts of healthcare data and need for data management is driving adoption of AI. While deep learning and natural language processing show potential, a lack of skilled labor and unclear regulations may impede market growth. The market is segmented by region, technology, offering, end use, and end user.
Patient flow management is a one-stop software solution to manage all the patient information in hospitals and plays a vital role in customer feedback and satisfaction. Reforming healthcare management and infrastructure in developing nations is expected to drive growth for global patient flow management solutions market during the forecast period.
Syringe market global trends, market share, industry size, growth, opportunit...Shubham Bhosale
Syringe Market Introduction
Medical syringes are widely used to administer injections, delivers drug intravenously to the bloodstream. The syringes which are commonly used include disposable syringes, pre-filled syringes, injection pens, needleless syringes and insulin pumps. The packaging materials for these syringes should be avoided fibres and clean peel opening, robust enough to withstand stress and it should reduce cost reduction by maximising safety and quality.
Smart insulin pen market global trends, market share, industry size, growth, ...Shubham Bhosale
The increasing diabetic population across the world seeks convenient solutions for diabetics’ management that are easy to recall and document insulin dosages as per blood sugar level of patients. Smart solutions can provide accurate diabetic management data in a timely fashion so that healthcare professionals could interpret pragmatic results based on the data and recommend appropriate treatment.
Insulin pens with smart connectivity are a major breakthrough in the era of digitization and innovation.
Michigan HealthTech Market Map 2024. Includes 7 categories: Policy Makers, Academic Innovation Centers, Digital Health Providers, Healthcare Providers, Payers / Insurance, Device Companies, Life Science Companies, Innovation Accelerators. Developed by the Michigan-Israel Business Accelerator
DECODING THE RISKS - ALCOHOL, TOBACCO & DRUGS.pdfDr Rachana Gujar
Introduction: Substance use education is crucial due to its prevalence and societal impact.
Alcohol Use: Immediate and long-term risks include impaired judgment, health issues, and social consequences.
Tobacco Use: Immediate effects include increased heart rate, while long-term risks encompass cancer and heart disease.
Drug Use: Risks vary depending on the drug type, including health and psychological implications.
Prevention Strategies: Education, healthy coping mechanisms, community support, and policies are vital in preventing substance use.
Harm Reduction Strategies: Safe use practices, medication-assisted treatment, and naloxone availability aim to reduce harm.
Seeking Help for Addiction: Recognizing signs, available treatments, support systems, and resources are essential for recovery.
Personal Stories: Real stories of recovery emphasize hope and resilience.
Interactive Q&A: Engage the audience and encourage discussion.
Conclusion: Recap key points and emphasize the importance of awareness, prevention, and seeking help.
Resources: Provide contact information and links for further support.
Can Allopathy and Homeopathy Be Used Together in India.pdfDharma Homoeopathy
This article explores the potential for combining allopathy and homeopathy in India, examining the benefits, challenges, and the emerging field of integrative medicine.
This particular slides consist of- what is Pneumothorax,what are it's causes and it's effect on body, risk factors, symptoms,complications, diagnosis and role of physiotherapy in it.
This slide is very helpful for physiotherapy students and also for other medical and healthcare students.
Here is a summary of Pneumothorax:
Pneumothorax, also known as a collapsed lung, is a condition that occurs when air leaks into the space between the lung and chest wall. This air buildup puts pressure on the lung, preventing it from expanding fully when you breathe. A pneumothorax can cause a complete or partial collapse of the lung.
About this webinar: This talk will introduce what cancer rehabilitation is, where it fits into the cancer trajectory, and who can benefit from it. In addition, the current landscape of cancer rehabilitation in Canada will be discussed and the need for advocacy to increase access to this essential component of cancer care.
Hypertension and it's role of physiotherapy in it.Vishal kr Thakur
This particular slides consist of- what is hypertension,what are it's causes and it's effect on body, risk factors, symptoms,complications, diagnosis and role of physiotherapy in it.
This slide is very helpful for physiotherapy students and also for other medical and healthcare students.
Here is summary of hypertension -
Hypertension, also known as high blood pressure, is a serious medical condition that occurs when blood pressure in the body's arteries is consistently too high. Blood pressure is the force of blood pushing against the walls of blood vessels as the heart pumps it. Hypertension can increase the risk of heart disease, brain disease, kidney disease, and premature death.
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to CareVITASAuthor
This webinar helps clinicians understand the unique healthcare needs of the LGBTQ+ community, primarily in relation to end-of-life care. Topics include social and cultural background and challenges, healthcare disparities, advanced care planning, and strategies for reaching the community and improving quality of care.
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - ...rightmanforbloodline
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - 34.
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - 34.
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - 34.
R3 Stem Cell Therapy: A New Hope for Women with Ovarian FailureR3 Stem Cell
Discover the groundbreaking advancements in stem cell therapy by R3 Stem Cell, offering new hope for women with ovarian failure. This innovative treatment aims to restore ovarian function, improve fertility, and enhance overall well-being, revolutionizing reproductive health for women worldwide.
International Cancer Survivors Day is celebrated during June, placing the spotlight not only on cancer survivors, but also their caregivers.
CANSA has compiled a list of tips and guidelines of support:
https://cansa.org.za/who-cares-for-cancer-patients-caregivers/
The best massage spa Ajman is Chandrima Spa Ajman, which was founded in 2023 and is exclusively for men 24 hours a day. As of right now, our parent firm has been providing massage services to over 50,000+ clients in Ajman for the past 10 years. It has about 8+ branches. This demonstrates that Chandrima Spa Ajman is among the most reasonably priced spas in Ajman and the ideal place to unwind and rejuvenate. We provide a wide range of Spa massage treatments, including Indian, Pakistani, Kerala, Malayali, and body-to-body massages. Numerous massage techniques are available, including deep tissue, Swedish, Thai, Russian, and hot stone massages. Our massage therapists produce genuinely unique treatments that generate a revitalized sense of inner serenely by fusing modern techniques, the cleanest natural substances, and traditional holistic therapists.
At Apollo Hospital, Lucknow, U.P., we provide specialized care for children experiencing dehydration and other symptoms. We also offer NICU & PICU Ambulance Facility Services. Consult our expert today for the best pediatric emergency care.
For More Details:
Map: https://cutt.ly/BwCeflYo
Name: Apollo Hospital
Address: Singar Nagar, LDA Colony, Lucknow, Uttar Pradesh 226012
Phone: 08429021957
Opening Hours: 24X7
Can coffee help me lose weight? Yes, 25,422 users in the USA use it for that ...nirahealhty
The South Beach Coffee Java Diet is a variation of the popular South Beach Diet, which was developed by cardiologist Dr. Arthur Agatston. The original South Beach Diet focuses on consuming lean proteins, healthy fats, and low-glycemic index carbohydrates. The South Beach Coffee Java Diet adds the element of coffee, specifically caffeine, to enhance weight loss and improve energy levels.
Can coffee help me lose weight? Yes, 25,422 users in the USA use it for that ...
Drug of abuse testing market global trends, market share, industry size, growth, opportunities, and market forecast 2019 to 2026
1. Drug of Abuse Testing Market Global Trends, Market Share, Industry Size, Growth,
Opportunities, and Market Forecast 2019 to 2026
Drug of Abuse Testing Market Introduction
Drug of abuse testing is a process of identification of illegal drugs in blood, urine,
saliva and others. The drugs include cocaine, opiates, marijuana, methamphetamine,
benzodiazepine, methadone, ecstasy, amphetamine, barbiturates, PCP and others.
Drug of abuse testing is a qualitative process and mostly performed in clinical
settings. In drug of abuse testing, sample collection is a critical process and requires
high integrity. Urine is the most preferable sample for the drug of abuse testing due
to the high window of detection and 75% of the clinical settings use urine for testing.
Saliva is the second preferable sample for the drug of abuse testing due to a simpler
process, but it has a narrow window of detection.
Drug of Abuse Testing Market Overview
Increasing illegal use of drugs for recreational purposes has fuelled the growth of
drug of abuse testing market. Further, increasing government pressure to control the
illicit drug usage among the adult population has led to the potential growth of the
drug of abuse testing market. Government agencies along with public organizations
are taking a direct part in controlling drug of abuse and launched many programs in
both the public & private sectors. Changing regulatory scenarios has created
significant opportunities for a drug of abuse testing manufacturers. Along with these,
technology has integrated the existing manual operations and boosted the
penetration. Technology has led to the development of a fully automated process
with a wide range of drug detection. Others factors like increasing awareness
boosted the robust growth of drug of abuse testing market.
North America Drug of Abuse Testing market witnessed significant share due to
stringent federal policies. It was followed by the European drug of abuse testing
market with stable market growth over the forecast period. Asia Pacific and Latin
America Drug of Abuse Testing market has witnessed fastest CAGR due to increasing
awareness.
Drug of Abuse Testing market manufacturers include Thermo Fisher Scientific,
SYNLAB, Siemens Healthcare Private Limited, Roche Diagnostics, Drägerwerk AG &
Co. KGaA, Beckman Coulter, Inc., Abbott Laboratories and others.
Request a Sample Report @ https://www.futurewiseresearch.com/request-
sample.aspx?id=12&page=requestsample
Report Structure:
Global Drug of Abuse Testing, by Test Type:
2. Immunoassay Test
Point-of-Care Tests
Chromatography Tests
Global Drug of Abuse Testing, by Sample Type:
Urine
Blood
Saliva
Global Drug of Abuse Testing, by End User:
Pathology Laboratories
Hospitals
Rehabilitation Centers
Federal Agencies
Forensic Laboratories
Clinics
Others
Global Drug of Abuse Testing, by Region:
Europe
North America
APAC
Latin America
Rest of World
Purchase a Copy & Ask For Discount: https://www.futurewiseresearch.com/request-
sample.aspx?id=12&page=askfordiscount
Competitive Landscape:
Tier 1 players- established companies in the market with major market share
Tier 2 players
Emerging players which are growing rapidly
New Entrants
3. FutureWise Takeaways
Growth prospects
SWOT analysis
Key trends
Key data-points
Objectives of the Study:
To provide with an exhaustive analysis on the global drug of abuse testing market on
the basis of test type, sample type, end-user and region
To cater comprehensive information on factors impacting market growth (drivers,
restraints, opportunities, and industry-specific restraints)
To evaluate and forecast micro-markets and overall market
To predict market size, in five key regions (along with countries)—North America,
Europe, Asia Pacific, Latin America, and the Middle East
To record evaluate and competitive landscape mapping- product launches,
technological advancements, mergers and expansions
Profiling of companies to evaluate their market shares, strategies, financials and core
competencies
Table of Contents
1. Introduction
1.1. Scope and Objective
1.2. Assumptions and Acronyms
1.3. Forecast Factors
1.4. Research Methodology
2. Executive Summary
2.1. Industry Cluster Analysis
2.2. Competition Matrix
2.3. Strategies Recommendations
3. Market Definition
3.1. Report Scope (Inclusions & Exclusions)
4. 3.2. Market Segmentation
4. Global Drug of Abuse Testing Market Overview
4.1. Global Drug of Abuse Testing Market Revenue (USD Mn)
5. Key Inclusions
5.1. Porter’s Five Force analysis
5.2. Market Dynamics
5.3. Industry Trends
5.4. Regulatory Guidelines
5.5. Opportunities in Drug of Abuse Testing
6. Competition Dynamics
6.1. Company Share Analysis (2019)
6.2. Top 10 Product Pricing by Region
7. Global Drug of Abuse Testing Market Revenue (USD Mn), 2019-2026 by Test
Type
7.1. Key Market Findings
7.2. Long Term ROI Segments
7.3. Revenue Opportunity Influencing Factors
7.4. Market Revenue (USD Mn) Assessment and Forecast by Test Type, 2019-2026
7.4.1 Immunoassay Test
7.4.2 POCT Tests
7.4.3 Chromatography Tests
7.4.4 Academic Institutes
8. Global Drug of Abuse Testing Market Revenue (USD Mn), 2019-2026 by Sample
Type
5. 8.1. Key Market Findings
8.2. Long Term ROI Segments
8.3. Revenue Opportunity Influencing Factors
8.4. Market Revenue (USD Mn) Assessment and Forecast by Sample
Type, 2019-2026
8.4.1 Urine
8.4.2 Saliva
8.4.3 Blood
8.4.4 Others
9. Global Drug of Abuse Testing Market Revenue (USD Mn), 2019-2026 by End
User
9.1. Key Market Findings
9.2. Long Term ROI Segments
9.3. Revenue Opportunity Influencing Factors
9.4. Market Revenue (USD Mn) Assessment and Forecast by End User, 2019-
2026
9.4.1 Pathology Laboratories
9.4.2 Hospitals
9.4.3 Rehabilitation Centres
9.4.4 Federal Agencies
9.4.5 Forensic Laboratories
9.4.6 Clinics
9.4.7 Others
10. Global Drug of Abuse Testing Market Revenue (USD Mn), 2019-2026 by Region
10.1.Key Market Findings
6. 10.2.Long Term ROI Segments
10.3.Revenue Opportunity Influencing Factors
10.4.Market Revenue (USD Mn) Assessment and Forecast by Region,2026
10.4.1 North America
10.4.2 Latin America
10.4.3 Europe
10.4.4 Asia Pacific
10.4.5 Rest of world
11. North America Drug of Abuse Testing Market Revenue (US$ Mn), 2019-2026
11.1. Key Market Findings
11.2. Long Term ROI Segments
11.3. Revenue Opportunity Influencing Factors
11.4. Market Revenue (USD Mn) Assessment and Forecast by Country,
2019-2026
11.4.1 US
11.4.2 Canada
11.5. Market Revenue (USD Mn) Assessment and Forecast by Test Type,
2019-2026
11.5.3 Immunoassay Test
11.5.4 POCT Tests
11.5.5 Chromatography Tests
11.5.6 Academic Institutes
11.6. Market Revenue (USD Mn) Assessment and Forecast by Sample
Type, 2019-2026
11.6.7 Urine
7. 11.6.8 Saliva
11.6.9 Blood
11.6.10 Others
11.7. Market Revenue (USD Mn) Assessment and Forecast by End User,
2019-2026
11.7.11 Pathology Laboratories
11.7.12 Hospitals
11.7.13 Rehabilitation Centres
11.7.14 Federal Agencies
11.7.15 Forensic Laboratories
11.7.16 Clinics
11.7.17 Others
12. Latin America Drug of Abuse Testing Market Revenue (US$ Mn), 2019-2026
12.1. Key Market Findings
12.2. Long Term ROI Segments
12.3. Revenue Opportunity Influencing Factors
12.4. Market Revenue (USD Mn) Assessment and Forecast by Country,
2019-2026
12.4.1 Brazil
12.4.2 Mexico
12.4.3 Argentina
12.4.4 Rest of Latin America
12.5. Market Revenue (USD Mn) Assessment and Forecast by Test Type,
2019-2026
12.5.5 Immunoassay Test
8. 12.5.6 POCT Tests
12.5.7 Chromatography Tests
12.5.8 Academic Institutes
12.6. Market Revenue (USD Mn) Assessment and Forecast by Sample
Type, 2019-2026
12.6.9 Urine
12.6.10 Saliva
12.6.11Blood
12.6.12 Others
12.7. Market Revenue (USD Mn) Assessment and Forecast by End User,
2019-2026
12.7.13 Pathology Laboratories
12.7.14 Hospitals
12.7.15 Rehabilitation Centres
12.7.16 Federal Agencies
12.7.17 Forensic Laboratories
12.7.18 Clinics
12.7.19 Others
13. Europe America Drug of Abuse Testing Market Revenue (US$ Mn), 2019-2026
13.1. Key Market Findings
13.2. Long Term ROI Segments
13.3. Revenue Opportunity Influencing Factors
13.4. Market Revenue (USD Mn) Assessment and Forecast by Country,
2019-2026
13.4.1 Germany
9. 13.4.2 France
13.4.3 Spain
13.4.4 UK
13.4.5 Russia
13.4.6 Poland
13.4.7 Rest of Europe
13.5. Market Revenue (USD Mn) Assessment and Forecast by Test Type,
2019-2026
13.5.8 Immunoassay Test
13.5.9 POCT Tests
13.5.10Chromatography Tests
13.5.11Academic Institutes
13.6. Market Revenue (USD Mn) Assessment and Forecast by Sample
Type, 2019-2026
13.6.12Urine
13.6.13Saliva
13.6.14Blood
13.6.15 Others
13.7. Market Revenue (USD Mn) Assessment and Forecast by End User,
2019-2026
13.7.16 Pathology Laboratories
13.7.17 Hospitals
13.7.18 Rehabilitation Centres
13.7.19 Federal Agencies
13.7.20 Forensic Laboratories
10. 13.7.21 Clinics
13.7.22 Others
14. Asia Pacific America Drug of Abuse Testing Market Revenue (US$ Mn), 2019-
2026
14.1. Key Market Findings
14.2. Long Term ROI Segments
14.3. Revenue Opportunity Influencing Factors
14.4. Market Revenue (USD Mn) Assessment and Forecast by Country,
2019-2026
14.4.1 Emerging Asia
14.4.1.1 China
14.4.1.2 India
14.4.1.3 ASEAN-5
14.4.1.4 Rest of Emerging Asia
14.4.2 Japan
14.5. Market Revenue (USD Mn) Assessment and Forecast by Test Type,
2019-2026
14.5.3 Immunoassay Test
14.5.4 POCT Tests
14.5.5 Chromatography Tests
14.5.6 Academic Institutes
14.6. Market Revenue (USD Mn) Assessment and Forecast by Sample
Type, 2019-2026
14.6.7 Urine
14.6.8 Saliva
11. 14.6.9 Blood
14.6.10 Others
14.7. Market Revenue (USD Mn) Assessment and Forecast by End User,
2019-2026
14.7.11 Pathology Laboratories
14.7.12 Hospitals
14.7.13 Rehabilitation Centres
14.7.14 Federal Agencies
14.7.15 Forensic Laboratories
14.7.16 Clinics
14.7.17 Others
15. Rest of World America Drug of Abuse Testing Market Revenue (US$ Mn), 2019-
2026
15.1. Key Market Findings
15.2. Long Term ROI Segments
15.3. Revenue Opportunity Influencing Factors
15.4. Market Revenue (USD Mn) Assessment and Forecast by Country,
2019-2026
15.4.1 Middle East
15.4.2 South Africa
15.4.3 North Africa
15.4.4 Rest of World
15.5. Market Revenue (USD Mn) Assessment and Forecast by Test Type,
2019-2026
15.5.5 Immunoassay Test
12. 15.5.6 POCT Tests
15.5.7 Chromatography Tests
15.5.8 Academic Institutes
15.6. Market Revenue (USD Mn) Assessment and Forecast by Sample
Type, 2019-2026
15.6.9 Urine
15.6.10Saliva
15.6.11Blood
15.6.12 Others
15.7. Market Revenue (USD Mn) Assessment and Forecast by End User,
2019-2026
15.7.13 Pathology Laboratories
15.7.14 Hospitals
15.7.15 Rehabilitation Centres
15.7.16 Federal Agencies
15.7.17 Forensic Laboratories
15.7.18 Clinics
15.7.19 Others
16. Company Profiles
16.1. Competition Landscape
16.2. Global Company Share (USD Mn) Overview, 2019
16.3. Company Profiles
16.3.1 Thermo Fisher Scientific
16.3.1.1 Corporate Overview
14. 16.3.6 Beckman Coulter, Inc.
16.3.6.1 Corporate Overview
16.3.6.2 Financial Performance
16.3.6.3 Peer Comparison & 3C marketing equation
16.3.6.4 Company Strategy & Channel Management
16.3.7 Abbott Laboratories
16.3.7.1 Corporate Overview
16.3.7.2 Financial Performance
16.3.7.3 Peer Comparison & 3C marketing equation
16.3.7.4 Company Strategy & Channel Management
17. Research Sources & Primary Verbatim
Inquire further details about this report at: sales@futurewiseresearch.com
About FutureWise Research:
We specialise in high-growth niche markets, assuring flexibility, agility and
customised solutions for our clients. Through in-depth market insights and
consultancy, we present our clients with the tools they need to be at the forefront of
their industry – a position secured for far more than the near future.
Contact Us:
Company Name: FutureWise Research
Contact Person: Vinay Thaploo
Email: sales@futurewiseresearch.com
Phone: +44 141 628 9353 / +1 970 279 4295
City: Leeds
Country: United Kingdom
Website: www.futurewiseresearch.com